Ningbo MedicalSystem Biotechnology Co.

Thanks to our well established facilities and highly qualified team, we are also professional and specialized in the clinical diagnostics service for our customers including diverse hospitals, healthcare centers, institutes and all other sectors in medical field. Medicalsystem successfully launched the IPO and was listed in SZSE (stock code: 300439) since 2015, the company has set up 4 regional R&D hubs around the world including facilities in headquarters Ningbo, Shenzhen, Changchun and San Diego, US. Pursuits of the excellence in quality of products and reaching an internationally recognized standard, Medicalsystem has been participating the IFCC-RELA since 2010 and all results were qualified since beginning, we also obtained the CE and ISO/TÜV certifications for our products and in our management practice. Till 2017, Medicalsystem has got over 130 registered and certified items of reagent in IVD field covering 11 categories of chemistry diagnostic items, including renal & liver function, blood lipid, cardiovascular disease, rheumatoid factors, diabetic disease while more than 5 different clinical analyzers. The company is dedicated to the principle of "Human-oriented innovation in Technology", It keeps empowering its force for healthcare in humanity, we deliver more reliability in diagnostics and more convenience in medical service.Creativity, Efficiency, Devotion and Responsibility, the values we are respecting and keeping for our mission and vision. Website home page|Disclaimer.|Site map